3Filing Date: Sep 11, 2026

HCA Healthcare

Initial Statement of Beneficial Ownership

View SEC Filing
ACC: 0001193125-26-389379
Total Value$0
Trades3
Insiders1

Transaction Details

Schlosser Michael J
EVP and Chief Clinical Officer·Direct
Common Stock
Shares0
Price-
Total Value$0
Shares Owned After170.1
Footnotes ▸

Includes 170.1027 shares acquired under the Issuer's employee stock purchase plans.

Schlosser Michael J
EVP and Chief Clinical Officer·Direct
Stock Appreciation RightDerivative
Shares0
Price-
Total Value$0
Exercise Price$81.96
ExpiresFeb 1, 2027
Holding Only
Footnotes ▸

The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018.

Schlosser Michael J
EVP and Chief Clinical Officer·Indirect · By 2022 Trust
Common Stock
Shares0
Price-
Total Value$0
Shares Owned After6.95K

Post-Transaction Holdings

Schlosser Michael J · EVP and Chief Clinical Officer
SecuritySharesChange
Common Stock7.12K-
Stock Appreciation Right--
Original SEC Filing Textexpand_more
=== SEC Form 3 — Statement of Changes in Beneficial Ownership === Document Type: 3 Period of Report: 2026-09-01 --- Issuer --- Name: HCA Healthcare, Inc. (HCA) CIK: 0000860730 --- Reporting Owner --- Name: Schlosser Michael J CIK: 0002149484 Role: Officer (EVP and Chief Clinical Officer) --- Holdings --- [Holding #1] Security: Common Stock Ownership: D (Direct) Footnotes: [F1] Includes 170.1027 shares acquired under the Issuer's employee stock purchase plans. [Holding #2] Security: Common Stock Ownership: I (Indirect) [Holding #3] Security: Stock Appreciation Right Ownership: D (Direct) Footnotes: [F2] The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018. [Holding #4] Security: Stock Appreciation Right Ownership: D (Direct) Footnotes: [F3] The stock appreciation rights vested in four equal annual installments beginning on May 3, 2018. [Holding #5] Security: Stock Appreciation Right Ownership: D (Direct) Footnotes: [F4] The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019. [Holding #6] Security: Stock Appreciation Right Ownership: D (Direct) Footnotes: [F5] The stock appreciation rights vested in four equal annual installments beginning on January 30, 2020. [Holding #7] Security: Stock Appreciation Right Ownership: D (Direct) Footnotes: [F6] The stock appreciation rights vested in four equal annual installments beginning on January 29, 2021. [Holding #8] Security: Stock Appreciation Right Ownership: D (Direct) Footnotes: [F7] The stock appreciation rights vested in four equal annual installments beginning on February 3, 2022. [Holding #9] Security: Stock Appreciation Right Ownership: D (Direct) Footnotes: [F8] The stock appreciation rights vested in four equal annual installments beginning on July 22, 2022. [Holding #10] Security: Stock Appreciation Right Ownership: D (Direct) Footnotes: [F9] The stock appreciation rights vested in four equal annual installments beginning on January 28, 2023. [Holding #11] Security: Stock Appreciation Right Ownership: D (Direct) Footnotes: [F10] The stock appreciation rights vest in four equal annual installments beginning on January 30, 2024. [Holding #12] Security: Stock Appreciation Right Ownership: D (Direct) Footnotes: [F11] The stock appreciation rights vest in four equal annual installments beginning on January 31, 2025. [Holding #13] Security: Stock Appreciation Right Ownership: D (Direct) Footnotes: [F12] The stock appreciation rights vest in four equal annual installments beginning on January 28, 2026. [Holding #14] Security: Stock Appreciation Right Ownership: D (Direct) Footnotes: [F13] The stock appreciation rights vest in four equal annual installments beginning on January 29, 2027. --- Footnotes (Complete Index) --- F1: Includes 170.1027 shares acquired under the Issuer's employee stock purchase plans. F10: The stock appreciation rights vest in four equal annual installments beginning on January 30, 2024. F11: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2025. F12: The stock appreciation rights vest in four equal annual installments beginning on January 28, 2026. F13: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2027. F2: The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018. F3: The stock appreciation rights vested in four equal annual installments beginning on May 3, 2018. F4: The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019. F5: The stock appreciation rights vested in four equal annual installments beginning on January 30, 2020. F6: The stock appreciation rights vested in four equal annual installments beginning on January 29, 2021. F7: The stock appreciation rights vested in four equal annual installments beginning on February 3, 2022. F8: The stock appreciation rights vested in four equal annual installments beginning on July 22, 2022. F9: The stock appreciation rights vested in four equal annual installments beginning on January 28, 2023. --- Signature --- /s/ /s/ Kevin A. Ball, Attorney-in-Fact (2026-09-11)

keid analysis is for reference only and does not constitute investment advice.